From this list they highlighted Fos-b, the binding target of FUS, with increased levels in FUS mutant motor neurons and conclude that this factor could be a key regulator of FUS-mutant axon branching in vitro and in vivo suggesting that Fos-B pathway could be a potential therapeutic target in future ALS research. This evidence concerns the gene FOSB and amyotrophic lateral sclerosis.